Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Barber

Showing results (91-100 of 254) with videos related to

Pageof 26
Sort By:
Social Science & Medicine (1982)|February 1, 2002
Smoking and quitting: a qualitative study with community-living psychiatric clientsSharon J Lawn, Rene G Pols, James G Barber
DICP : the Annals of Pharmacotherapy|December 1, 1991
Topical uses of testosteroneJ V Etzel, A Y Lin, P G Barber
Medical Education|January 12, 2021
Transforming existing norms for payment and legitimacy of 'teaching work' in medical educationSophie E Park, Hugh Alberti, John R G Barber
Bulletin of Environmental Contamination and Toxicology|February 1, 1988
Seasonal resistance of the shore crab, Hemigrapsus oregonesis, to saxitoxin injectionsK G Barber, D D Kitts, P M Townsley
Mutagenesis|November 1, 1987
Positive and negative control observations for the in vivo/in vitro rat liver assay for unscheduled DNA synthesis (UDS)J Ashby, R W Trueman, R Mohammed, et al.
Bioorganic & Medicinal Chemistry Letters|January 5, 2002
Selective urokinase-type plasminogen activator (uPA) inhibitors. Part 1: 2-PyridinylguanidinesChristopher G Barber, Roger P Dickinson, Valerie A Horne
Canadian Journal of Surgery. Journal Canadien De Chirurgie|October 1, 1994
Venous gangrene of the extremitiesJ W Lorimer, L C Semelhago, G G Barber
Journal of Veterinary Internal Medicine|November 3, 2010
Efficacy of maropitant in the prevention of delayed vomiting associated with administration of doxorubicin to dogsS E Rau, L G Barber, K E Burgess
Biomedicines|April 3, 2021
Copper Toxicity Is Not Just Oxidative Damage: Zinc Systems and Insight from Wilson DiseaseR G Barber, Zoey A Grenier, Jason L Burkhead
Bioorganic & Medicinal Chemistry Letters|May 20, 2004
Selective urokinase-type plasminogen activator (uPA) inhibitors. Part 3: 1-isoquinolinylguanidinesChristopher G Barber, Roger P Dickinson, Paul V Fish
Pageof 26

Showing results (91-100 of 254) with videos related to

Sort By:
Pageof 26
Social Science & Medicine (1982)|February 1, 2002
Smoking and quitting: a qualitative study with community-living psychiatric clientsSharon J Lawn, Rene G Pols, James G Barber
DICP : the Annals of Pharmacotherapy|December 1, 1991
Topical uses of testosteroneJ V Etzel, A Y Lin, P G Barber
Medical Education|January 12, 2021
Transforming existing norms for payment and legitimacy of 'teaching work' in medical educationSophie E Park, Hugh Alberti, John R G Barber
Bulletin of Environmental Contamination and Toxicology|February 1, 1988
Seasonal resistance of the shore crab, Hemigrapsus oregonesis, to saxitoxin injectionsK G Barber, D D Kitts, P M Townsley
Mutagenesis|November 1, 1987
Positive and negative control observations for the in vivo/in vitro rat liver assay for unscheduled DNA synthesis (UDS)J Ashby, R W Trueman, R Mohammed, et al.
Bioorganic & Medicinal Chemistry Letters|January 5, 2002
Selective urokinase-type plasminogen activator (uPA) inhibitors. Part 1: 2-PyridinylguanidinesChristopher G Barber, Roger P Dickinson, Valerie A Horne
Canadian Journal of Surgery. Journal Canadien De Chirurgie|October 1, 1994
Venous gangrene of the extremitiesJ W Lorimer, L C Semelhago, G G Barber
Journal of Veterinary Internal Medicine|November 3, 2010
Efficacy of maropitant in the prevention of delayed vomiting associated with administration of doxorubicin to dogsS E Rau, L G Barber, K E Burgess
Biomedicines|April 3, 2021
Copper Toxicity Is Not Just Oxidative Damage: Zinc Systems and Insight from Wilson DiseaseR G Barber, Zoey A Grenier, Jason L Burkhead
Bioorganic & Medicinal Chemistry Letters|May 20, 2004
Selective urokinase-type plasminogen activator (uPA) inhibitors. Part 3: 1-isoquinolinylguanidinesChristopher G Barber, Roger P Dickinson, Paul V Fish
Pageof 26